REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
REACTiVe-2：转移性胰腺癌患者接受 (m)FOLFIRINOX 方案治疗后，树突状细胞疫苗接种和激动性 CD40 疗法的 I 期评估
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-66092-1.
Songul Kucukcelebi # ,Freek R van 't Land # ,Sjoerd H van der Burg ,Ferry A L M Eskens ,Marjolein Y V Homs ,Marcella Willemsen ,Anne Onrust-van Schoonhoven ,Nina E M Rozendaal ,Amine Fellah ,Disha Vadgama ,Miranda Moskie ,Koen Bezemer ,Michail Doukas ,Casper W F van Eijck ,Ralph Stadhouders ,Judith de Vos-Geelen ,Aniek E van Diepen ,Ilona Enninga ,Rob Meijer ,Sumeet V Ambarkhane ,Peter Ellmark ,Joachim G J V Aerts ,Christianne Groeneveldt ,Casper H J van Eijck
